Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases

[Figure: see text]

Detalles Bibliográficos
Autores principales: Melicine, Sophie, Billoir, Paul, Faille, Dorothée, Grove, Erik Lerkevang, Lê, Minh P., Ajzenberg, Nadine, Smadja, David M., Gendron, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439387/
https://www.ncbi.nlm.nih.gov/pubmed/37601026
http://dx.doi.org/10.1016/j.rpth.2023.100201
_version_ 1785092932570710016
author Melicine, Sophie
Billoir, Paul
Faille, Dorothée
Grove, Erik Lerkevang
Lê, Minh P.
Ajzenberg, Nadine
Smadja, David M.
Gendron, Nicolas
author_facet Melicine, Sophie
Billoir, Paul
Faille, Dorothée
Grove, Erik Lerkevang
Lê, Minh P.
Ajzenberg, Nadine
Smadja, David M.
Gendron, Nicolas
author_sort Melicine, Sophie
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-10439387
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104393872023-08-20 Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases Melicine, Sophie Billoir, Paul Faille, Dorothée Grove, Erik Lerkevang Lê, Minh P. Ajzenberg, Nadine Smadja, David M. Gendron, Nicolas Res Pract Thromb Haemost Research Letter [Figure: see text] Elsevier 2023-06-08 /pmc/articles/PMC10439387/ /pubmed/37601026 http://dx.doi.org/10.1016/j.rpth.2023.100201 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Melicine, Sophie
Billoir, Paul
Faille, Dorothée
Grove, Erik Lerkevang
Lê, Minh P.
Ajzenberg, Nadine
Smadja, David M.
Gendron, Nicolas
Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title_full Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title_fullStr Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title_full_unstemmed Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title_short Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
title_sort dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439387/
https://www.ncbi.nlm.nih.gov/pubmed/37601026
http://dx.doi.org/10.1016/j.rpth.2023.100201
work_keys_str_mv AT melicinesophie dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT billoirpaul dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT failledorothee dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT groveeriklerkevang dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT leminhp dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT ajzenbergnadine dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT smadjadavidm dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases
AT gendronnicolas dabigatranreversalfailureusingstandarddoseofidarucizumabasystematicreviewandmetaanalysisofcases

Ejemplares similares